Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Joel Gelernter

Director, Division of Human Genetics (Psychiatry) Professor of Psychiatry and Professor of Genetics and of Neuroscience School of Medicine   Yale University,United States.   

Biography

Joel Gelernter completed his MD in SUNY Downstate Medical Center (1983).He is the Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience and Director, Division of Human Genetics (Psychiatry).

Research Interest

He established Center for the Translational Neuroscience of Alcoholism , Human Genetics, Division of Molecular Psychiatry, Division of Psychotherapy Development Center, Stress & Addiction Clinical Research Program, VA Alcohol Research Center , VA-Yale Clinical Neurosciences PTSD Research Program  Yale Global Mental Health Program.

 

Publications
Relevant Topics
Top